<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment

pmid: 17264803
Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment
To examine the association between polymorphisms in the dopamine transporter gene (SLC6A3, DAT1) and treatment outcome in smokers attempting to quit using either nicotine replacement therapy or bupropion.The sample consisted of 583 smokers recruited from a smoking cessation clinic, and followed throughout the 4 weeks of post-cessation treatment with behavioural support and either nicotine replacement therapy or bupropion.At 1 week after smoking cessation, the 3' untranslated region (3'UTR) variable number of tandem repeats (VNTRs) and the 30-bp intron 8 VNTR DAT1 genotypes were associated with the ability to stop smoking (3'UTR VNTR, odds ratio=2.0, 95% confidence interval=1.2-3.5, novel intron 8 VNTR, odds ratio=1.8, 95% confidence interval=1.0-2.9), controlling for potential confounders. The results were weaker and no longer significant at a 4-week follow-up.We find evidence, although modest, of a medium-sized effect of DAT1 genotype on the ability to stop smoking early in a smoking cessation attempt. If the effect is real, and is strongest in the very early stages of smoking cessation, this suggests that the primary utility of DAT1 screening in this field will be in the identification of those most at risk of early relapse after quitting.
- King's College London, University of London
- King's College London United Kingdom
Adult, Male, Dopamine Plasma Membrane Transport Proteins, Nicotine, Polymorphism, Genetic, Genotype, Smoking, Smoking Prevention, Minisatellite Repeats, Middle Aged, Treatment Outcome, Dopamine Uptake Inhibitors, 616, Humans, Female, Smoking Cessation, Nicotinic Agonists, 3' Untranslated Regions, Bupropion
Adult, Male, Dopamine Plasma Membrane Transport Proteins, Nicotine, Polymorphism, Genetic, Genotype, Smoking, Smoking Prevention, Minisatellite Repeats, Middle Aged, Treatment Outcome, Dopamine Uptake Inhibitors, 616, Humans, Female, Smoking Cessation, Nicotinic Agonists, 3' Untranslated Regions, Bupropion
4 Research products, page 1 of 1
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).47 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%